Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net loss attributable to Flotek Industries, Inc. (Flotek)	$ (74,967,000)	$ (15,803,000)
Loss from discontinued operations, net of tax	0	(13,937,000)
Loss from continuing operations	(74,967,000)	(1,866,000)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	6,027,000	6,023,000
Amortization of deferred financing costs	192,000	253,000
Provision for excess and obsolete inventory	1,942,000	280,000
Impairment of goodwill	37,180,000	0
Loss on write-down of assets held for sale	2,580,000	0
Loss on sale of assets	62,000	412,000
Stock compensation expense	4,385,000	6,653,000
Deferred income tax provision (benefit)	15,587,000	(7,329,000)
Reduction in tax benefit related to share-based awards	120,000	315,000
Changes in current assets and liabilities:
Accounts receivable, net	2,736,000	(12,874,000)
Inventories, net	(17,112,000)	(20,303,000)
Income taxes receivable	15,000	8,619,000
Other current assets	1,147,000	14,185,000
Accounts payable	3,675,000	(1,418,000)
Accrued liabilities	(2,556,000)	(180,000)
Income taxes payable	0	(10,000)
Interest payable	(19,000)	(3,000)
Net cash used in operating activities	(19,006,000)	(7,243,000)
Cash flows from investing activities:
Capital expenditures	(3,227,000)	(4,508,000)
Proceeds from sales of businesses	0	17,490,000
Proceeds from sale of assets	90,000	310,000
Purchase of patents and other intangible assets	(215,000)	(247,000)
Net cash (used in) provided by investing activities	(3,352,000)	13,045,000
Cash flows from financing activities:
Repayments of indebtedness	0	(9,833,000)
Borrowings on revolving credit facility	146,038,000	224,757,000
Repayments on revolving credit facility	(124,862,000)	(220,607,000)
Debt issuance costs	(98,000)	(106,000)
Purchase of treasury stock related to share-based awards	(24,000)	(1,335,000)
Proceeds from sale of common stock	247,000	368,000
Repurchase of common stock	0	(487,000)
Proceeds from exercise of stock options	0	20,000
Loss from noncontrolling interest	(357,000)	0
Net cash provided by (used in) financing activities	20,944,000	(7,223,000)
Discontinued operations:
Net cash used in operating activities	0	(794,000)
Net cash provided by investing activities	0	794,000
Net cash flows provided by discontinued operations	0	0
Effect of changes in exchange rates on cash and cash equivalents	(74,000)	20,000
Net decrease in cash and cash equivalents	(1,488,000)	(1,401,000)
Cash and cash equivalents at the beginning of period	4,584,000	4,823,000
Cash and cash equivalents at the end of period	$ 3,096,000	$ 3,422,000